New drug aims to ease severe facial pain in trigeminal neuralgia
NCT ID NCT06571448
First seen Jan 11, 2026 · Last updated May 22, 2026 · Updated 21 times
Summary
This study tested a new drug called SR750 in 138 people with trigeminal neuralgia, a condition that causes sudden, severe facial pain. Participants took either the study drug or a placebo for 6 weeks and recorded their daily pain levels. The goal was to see if SR750 could safely reduce the average pain score compared to placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRIGEMINAL NEURALGIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
China-Japan Friendship Hospital
Beijing, China
Conditions
Explore the condition pages connected to this study.